Page last updated: 2024-08-23

captopril and 8-((4-chlorophenyl)thio)cyclic-3',5'-gmp

captopril has been researched along with 8-((4-chlorophenyl)thio)cyclic-3',5'-gmp in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, LY; Guh, JY; Huang, JS; Hwang, JY; Kan, WC; Liu, YB; Yang, YL1

Other Studies

1 other study(ies) available for captopril and 8-((4-chlorophenyl)thio)cyclic-3',5'-gmp

ArticleYear
Angiotensin-converting enzyme inhibitors attenuated advanced glycation end products-induced renal tubular hypertrophy via enhancing nitric oxide signaling.
    Journal of cellular physiology, 2019, Volume: 234, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Enlargement; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enalapril; Enzyme Activation; Glycation End Products, Advanced; Humans; Hypertrophy; Kidney Tubules, Proximal; MAP Kinase Signaling System; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Thionucleotides

2019